Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A

Frank M. Horling, Birgit M. Reipert, Peter Allacher, Werner Engl, Luying Pan, Srilatha Tangada

Blood Adv (2024) 8 (11): 2726–2739.

https://doi.org/10.1182/bloodadvances.2023011780

Published: 2024

Includes: Supplemental data

Journal Articles

Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication

Helmut Paul, Verena Berg, Bagirath Gangadharan, Joel Bowen, Petra LeBeau, Jan Blatný, Christoph Male, Vlad C. Radulescu, Rosa Diaz, Maria Elisa Mancuso, Deborah L. Brown, Birgit M. Reipert

Blood Adv (2023) 7 (9): 1831–1848.

https://doi.org/10.1182/bloodadvances.2022007267

Published: 2023

Includes: Supplemental data

Journal Articles

Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study

Olga Oleshko, Sonja Werwitzke, Annika Klingberg, Torsten Witte, Hermann Eichler, Robert Klamroth, Katharina Holstein, Christina Hart, Christian Pfrepper, Paul Knöbl, Richard Greil, Peter Neumeister, Birgit M. Reipert, Andreas Tiede

Blood Adv (2023) 7 (1): 122–130.

https://doi.org/10.1182/bloodadvances.2022008071

Published: 2023

Journal Articles

Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors

Helmut Schweiger, Judit Rejtő, Christoph J. Hofbauer, Verena Berg, Peter Allacher, Karl Zwiauer, Clemens Feistritzer, Gerhard Schuster, Cihan Ay, Birgit M. Reipert, Ingrid Pabinger

Blood Adv (2022) 6 (3): 946–958.

https://doi.org/10.1182/bloodadvances.2021005745

Published: 2022

Includes: Supplemental data